Deposition of JPMorgan CEO Dimon in Jeffrey Epstein lawsuits set for late May, source says
Jeffrey Epstein, a sex offender who had been friends with former presidents Donald Trump and Bill Clinton, was a customer of JPMorgan Chase for years.
Chegg shares rebound with 17% pop after losing almost half their value on ChatGPT concerns
Chegg CEO Dan Rosensweig told CNBC late Tuesday that the stock’s 48% plunge during regular trading hours was “extraordinarily overblown.”
Google is making it easier to log in to its services without a password
Instead of having to remember a password for each service you use, passkeys allow you to enter a PIN code or verify your identity with your fingerprint or face.
A looming El Niño could prompt a spike in global temperatures, UN agency warns
The United Nations agency said it cannot yet forecast the strength or duration of the El Niño later this year.
FTC Chair Lina Khan says she’s on alert for abusive A.I. use
Khan compared the current AI inflection point to the era in tech when Facebook and Google came to change communications, but with substantial privacy risks.
Private payrolls surged by 296,000 in April, much higher than expected, ADP says
Private payrolls growth was above the downwardly revised 142,000 the previous month and well ahead of the Dow Jones estimate for 133,000.
Olive Garden owner Darden Restaurants buys Ruth’s Chris Steak House for $715 million
Ruth’s Chris Steak House has more than 150 locations worldwide and generated $505.9 million in revenue in 2022.
Mortgage demand drops as bank failures hit jumbo loan rates
Mortgage demand dropped last week despite a slight easing in interest rates, while trouble in the banking sector makes jumbo loans more expensive.
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Donanemab, a monthly antibody infusion made by pharmaceutical company Eli Lilly, also significantly reduced brain plaque associated with Alzheimer’s disease.
